Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Impaired Glucose Metabolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01754792
What this trial is testing

Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose Subjects

Who this might be right for
Type 2 DiabetesImpaired Glucose ToleranceHealthy
University of Valencia 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04341571
What this trial is testing

Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.

Who this might be right for
PreDiabetesImpaired Glucose ToleranceHyperglycemia+1 more
University of Guadalajara 30
Not applicableStudy completedNCT02896010
What this trial is testing

Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes

Who this might be right for
PrediabetesHyperglycemiaPostprandial Hyperglycemia+2 more
Johns Hopkins University 55
Large-scale testing (Phase 3)Study completedNCT00663260
What this trial is testing

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 631
Not applicableStudy completedNCT03578991
What this trial is testing

Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease

Who this might be right for
Patients Aged 65-85 (Both Included)Diagnosed of Mild Cognitive ImpairmentDiagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years
Parc Sanitari Pere Virgili 54
Early research (Phase 1)Study completedNCT06246175
What this trial is testing

HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Not applicableEnded earlyNCT06537401
What this trial is testing

Metabolic Adaptations to High-fat Diet

Who this might be right for
AdiposityInsulin SensitivityImpaired Glucose Tolerance+1 more
George Washington University 2
Post-approval studies (Phase 4)Study completedNCT00456885
What this trial is testing

The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women

Who this might be right for
ObesityImpaired Glucose Tolerance
Beth Israel Deaconess Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT00886626
What this trial is testing

GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children

Who this might be right for
Obesity, Morbid
University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT00847899
What this trial is testing

Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance

Who this might be right for
HypertensionImpaired Glucose Tolerance
Arete Therapeutics 150
Not applicableStudy completedNCT01420198
What this trial is testing

Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study.

Who this might be right for
Type 2 DiabetesImpaired Glucose ToleranceObesity+1 more
Region Skane 96
Early research (Phase 1)Study completedNCT02115347
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)

Who this might be right for
Type 2 Diabetes MellitusHepatic Impairment
Merck Sharp & Dohme LLC 16
Not applicableUnknownNCT05484817
What this trial is testing

Early Assessment of Impaired Cardiac Function in Patients With Diabetes Mellitus

Who this might be right for
Diabetes MellitusLeft Ventricular Dysfunction
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 300
Early research (Phase 1)Study completedNCT01907113
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 40
Not applicableUnknownNCT06520995
What this trial is testing

Elderly Patients With Type 2 Diabetes and Cognitive Exercises

Who this might be right for
Cognitive ImpairmentDiabetes Mellitus, Type 2Diabetes Complications
Istanbul University - Cerrahpasa 90
Not applicableUnknownNCT03482869
What this trial is testing

Evaluation of Self-reported Walking Impairment in Predominantly Illiterate Patients

Who this might be right for
Diabetes
Université Polytechnique de Bobo-Dioulasso 150
Large-scale testing (Phase 3)Study completedNCT03697109
What this trial is testing

The Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

Who this might be right for
Cushing Syndrome
Corcept Therapeutics 152
Large-scale testing (Phase 3)Study completedNCT04308590
What this trial is testing

The Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas

Who this might be right for
Hypercortisolism
Corcept Therapeutics 137
Not applicableStudy completedNCT01787903
What this trial is testing

The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA

Who this might be right for
Type 1 Diabetes MellitusHypoglycemia Unawareness
Amsterdam UMC, location VUmc 52
Not applicableUnknownNCT05994586
What this trial is testing

The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism

Who this might be right for
Diabetes in AdolescencePreDiabetes
AronPharma Sp. z o. o. 30
Next Page